Skip to main content
. 2000 Apr;38(4):1552–1558. doi: 10.1128/jcm.38.4.1552-1558.2000

TABLE 2.

Influenza virus reference strains used to evaluate the specificity of the TaqMan-PCRa

Influenza virus strains CT ofb:
Type B-PCR Type A-PCR Subtype A H1-PCR Subtype A H3-PCR
Influenza A (H1N1)
 A/PR/8/34 Neg 22 23 Neg
 A/Singapore/6/86 Neg 24 24 Neg
 A/Taiwan/1/86 Neg 22 23 Neg
 A/Texas/36/91 Neg 23 22 Neg
 A/Bayern/7/95 Neg 21 22 Neg
Influenza A (H3N2)
 A/Leningrad/360/86 Neg 19 Neg 20
 A/Sichuan/2/87 Neg 18 Neg 20
 A/Shanghai/11/87 Neg 22 Neg 19
 A/England/427/88 Neg 20 Neg 21
 A/Guizhou/54/89 Neg 19 Neg 19
 A/Beijing/353/89 Neg 21 Neg 20
 A/Beijing/32/92 Neg 18 Neg 20
 A/Shangdong/9/93 Neg 19 Neg 22
 A/Johannesburg/33/94 Neg 19 Neg 21
 A/Wuhan/353/95 Neg 20 Neg 19
 A/Nanchang/933/95 Neg 19 Neg 18
 A/Sydney/5/97 Neg 18 Neg 18
Influenza B
 B/USSR/100/83 23 Neg Neg Neg
 B/Ann Arbor/1/86 24 Neg Neg Neg
 B/Victoria/2/87 22 Neg Neg Neg
 B/Yamagata/16/88 22 Neg Neg Neg
 B/Panama/45/90 23 Neg Neg Neg
 B/Quindao/102/91 20 Neg Neg Neg
 B/Beijing/184/93 21 Neg Neg Neg
 B/Harbin/7/94 19 Neg Neg Neg
 B/Belarus/1/95 22 Neg Neg Neg
a

PCR amplification was performed by running 45 cycles with each of the type- and subtype-specific primer/probe systems. 

b

Neg, negative (no increase in fluorescence and, therefore, no amplification was detected during the 45 cycles).